Author(s):
Kori Yati, Septiana Tri Pamungkas, Fitria Nugrahaeni, Fith Khaira Nursal
Email(s):
fithkhaira@uhamka.ac.id
DOI:
10.52711/0974-360X.2026.00300 
Address:
Kori Yati1,2, Septiana Tri Pamungkas1, Fitria Nugrahaeni2, Fith Khaira Nursal1,2*
1Magister of Pharmaceutical Science, School of Postgraduate, Universitas Muhammadiyah Prof. Dr. Hamka Jakarta, Indonesia.
2Pharmacy Study Program, Faculty of Pharmacy and Science, Universitas Muhammadiyah Prof. Dr. Hamka, Jakarta, Indonesia.
*Corresponding Author
Published In:
Volume - 19,
Issue - 5,
Year - 2026
ABSTRACT:
Ketoconazole is an antifungal drug from the Imidazole group and Biopharmaceutical Classification System (BCS) class II with very low water solubility, high permeability, and low bioavailability when administered orally. The purpose of this study was to test the physical stability of the ketoconazole niosome system, based on the previous Formula, using a combination of Span 60(S-60) and Sucrose Ester Palmitat (SEP) as surfactants with Hydrophile Lipophile Balance (HLB) values of 7 and 7.5. Evaluation of niosomes included particle size, polydispersity index, zeta potential, entrapment efficiency test, morphology imaging, and drug release test carried out for 12 weeks at temperatures of 4, 25 and 40ºC. The results showed changes in particle size, polydispersity index and zeta potential at temperatures of 4, 25 and 40ºC. The drug absorption efficiency test showed changes in the formula with HLB values of 7 and 7.5, from the storage at different temperatures (week 0 to week 12). Drug release test showed a decrease for two formulas (F1 and F2) at different temperatures, but they still meet the requirements. The results of the stability test showed that ketoconazole niosomes were stable when stored at 4 and 25ºC because they did not experience signific.
Cite this article:
Kori Yati, Septiana Tri Pamungkas, Fitria Nugrahaeni, Fith Khaira Nursal. Niosome of Ketoconazole Delivery System: Optimisation Formulation and Stability Test. Research Journal Pharmacy and Technology. 2026;19(5):2089-6. doi: 10.52711/0974-360X.2026.00300
Cite(Electronic):
Kori Yati, Septiana Tri Pamungkas, Fitria Nugrahaeni, Fith Khaira Nursal. Niosome of Ketoconazole Delivery System: Optimisation Formulation and Stability Test. Research Journal Pharmacy and Technology. 2026;19(5):2089-6. doi: 10.52711/0974-360X.2026.00300 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-5-21
REFERENCES:
1. Hidayat R. Hubungan Kebersihan Diri (Personal Hygiene) dengan Kejadian Penyakit Dermatofitosis di Desa Lereng Wilayah Kerja Puskesmas Kuok. Jurnal NERS. 2018; 2(1): 86–94.
2. Xu Y, Lu H, Zhu S, Li WQ, Jiang YY, Berman J, Yang F. Multifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans. Microbiol Spectr [Internet]. 2021; 9(1). Available from: https://doi.org/10.1128/Spectrum.00321
3. Dudhipala N, AY AA. Amelioration of Ketoconazole in Lipid Nanoparticles for Enhanced Antifungal Activity and Bioavailability Through Oral Administration for Management of Fungal Infections. Chem Phys Lipids. 2020; 232.
4. Sodeifian G, Sajadian SA, Razmimanesh F, Hazaveie SM. Solubility of Ketoconazole (Antifungal Drug) in SC-CO2 for Binary and Ternary Systems: Measurements and Empirical Correlations. Sci Rep. 2021; 11(1).
5. Karpe MS. Development and Evaluation of Controlled Release Mefenamic Acid Loaded Nano Sponge Capsules for the Treatment of Rheumatoid Arthritis. Res J Pharm Technol. 2025; 18(5).
6. Sipos E, Kósa N, Kazsoki A, Szabó ZI, Zelkó R. Formulation and Characterization of Aceclofenac-Loaded Nanofiber Based Orally Dissolving Webs. Pharmaceutics. 2019; 11(8).
7. Guillot AJ, Martínez-Navarrete M, Garrigues TM, Melero A. Skin Drug Delivery Using Lipid Vesicles: A Starting Guideline for Their Development. J Control Release. 2023; 355: 624–54.
8. Gupta SC, Patil Y V, Sargar LR, Panhalkar SB, Sonawane PD, Mane S V. Formulation and Evaluation of Diclofenac Sodium Nanosuspension. Res J Pharm Technol. 2025; 18(5).
9. Hamza, Nimisha, Singh A. Current Insights on Preparation Methods and Characterisation of Nanoparticles. Res J Pharm Technol. 2025; 18(5).
10. Chen S, Hanning S, Falconer J, Locke M, Wen J. Recent Advances in Non-ionic Surfactant Vesicles (Niosomes): Fabrication, Characterization, Pharmaceutical and Cosmetic Applications. Eur J Pharm Biopharm. 2019; 144: 18–39.
11. Abhishek S. P, Bilal J. S, Ankush S. B, Indrayani D. R, Manojkumar M. N. Niosomes: A Promising Drug Delivery Carrier. Int Journal of Pharmaceutical Sciences and Medicine. 2021;6(6):15–27.
12. Singh B, Sharma P, Bose S, Thakur J, Saini G, Vyas M. Niosomes: The Current and Future Perspectives in Drug Delivery System. Res J Pharm Technol. 2021; 14(7): 3961–6.
13. Govindarajan S, Swamivelmanickam M, Nair SP, Sivagnanam S. A Comprehensive Study on Provesicular Drug Delivery System: Proniosomal Gel. Indian J Pharm Sci. 2022; 84(1): 1–13. Available from: www.ijpsonline.com
14. Olii AT, Nugroho AK, Martien R, Riyanto S. Effect of Ratio Span 60 - Cholesterol on the Characteristic of Niosomes Vitamin D3. Res J Pharm Technol. 2022; 15(12): 5551–4.
15. Kumar GP, Rajeshwarrao P. Nonionic Surfactant Vesicular Systems for Effective Drug Delivery—an Overview. Acta Pharm Sin B. 2011; 1(4): 208–19.
16. Abu El-Enin AS, Khalifa MK, Dawaba A, Dawaba H. Proniosomal Gel-Mediated Topical Delivery of Fluconazole: Development, in Vitro Characterization, and Microbiological Evaluation. J Adv Pharm Technol Res. 2019; 10(1): 20.
17. Rasul A, Khan MI, Rehman MU, Abbas G, Aslam N, Ahmad S, Abbas K, Shah P, Iqbal M, Subari A, Shaheer T, Shah S. In Vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for The Prolonged Delivery of an Immunosuppressant Model Drug. Int J Nanomedicine. 2020; 15: 7937–49.
18. Compass Food. Compass Food. 2023 [cited 2023 Dec 15]. Habo monoester P90. Available from: https://www.compassfoods.com/habo-monoester-p90.html
19. Pamungkas ST, Nursal FK, Nugrahaeni F, Yati K. Formulation of Ketoconazole Niosomal Delivery System using Non-Ionic Surfactants. Trop J Nat Prod Res. 2024; 8(12): 9626–31.
20. European Medicines Agency. ICH guideline Q14 on analytical procedure development [Internet]. 2022. Available from: www.ema.europa.eu/contact
21. Diksha, Kumar P, Verma N. An overview on niosomes: As an auspesious drug delivery system on the bases of application. Res J Pharm Technol. 2021; 14(5): 2896–902.
22. Shirsand S, Kanani K, Keerthy D, Nagendrakumar D, Para M. Formulation and Evaluation of Ketoconazole Niosomal Gel Drug Delivery System. Int J Pharm Investig. 2012; 2(4): 201.
23. De Silva L, Fu JY, Htar TT, Muniyandy S, Kasbollah A, Wan Kamal WHB, Chuah L. Characterization, Optimization, and In Vitro Evaluation of Technetium-99m-labeled Niosomes. Int J Nanomedicine. 2019; 14: 1101–17.
24. Ghosh MK, Khan MdRI, Rony SR, Mukherjee B, Uddin MKM, Banu S, Barman R. Design, Optimization and In vitro Assessment of Rifampicin Loaded Self-Nanoemulsifying Drug Delivery System. Res J Pharm Technol. 2025;18(6).
25. Barot M, Prajapati AP, Vadgama N, Narkhede SB, Luhar S. Formulation Development and Evaluation of Proniosomal Gel containing Crisaborole. Res J Pharm Technol. 2025; 18(5).
26. Verma V, Singh UK. Ketoconazole HPLC Method Development and Validation: A Novel Approach. Int Res J Pharm. 2017; 8(8): 74–81.
27. Ghumman SA, Ijaz A, Noreen S, Aslam A, Kausar R, Irfan A, Latif S, Shazly G, Shah P, Rana M, Aslam A, Altaf M, Kotwica-Mojzych K, Bin Jardan Y. Formulation and Characterization of Curcumin Niosomes: Antioxidant and Cytotoxicity Studies. Pharmaceuticals. 2023; 16(10).
28. Chauhan R, Malik A. Preparation of Drug Aloin Nanoparticles for Enhanced Bioavailability and Optimization by using a Drug Design Stat-ease software. Res J Pharm Technol. 2025;18(1).
29. Dave V, Sharma S, Yadav RB, Agarwal U. Herbal Liposome for The Topical Delivery of Ketoconazole for The Effective Treatment of Seborrheic Dermatitis. Appl Nanosci. 2017; 7(8): 973–87.
30. Mashal M, Attia N, Grijalvo S, Eritja R, Puras G, Pedraz JL. Stability of Polymeric Cationic Niosomes and Their Plasmid DNA-based Complexes as Gene Delivery Carriers. Drug Deliv. 2023;30(1).
31. Liga S, Paul C, Moacă EA, Péter F. Niosomes: Composition, Formulation Techniques, and Recent Progress as Delivery Systems in Cancer Therapy. Pharmaceutics. 2024; 16.
32. Owodeha-Ashaka K, Ilomuanya MO, Iyire A. Evaluation of Sonication on Stability-indicating Properties of Optimized Pilocarpine Hydrochloride-loaded Niosomes in Ocular Drug Delivery. Prog Biomater. 2021; 10(3): 207–20.
33. Nath RS, Boraste SS, Shinkar DM, Amrutkar SV, Pingale PL. Formulation, Development, and Optimization of Cefpodoxime Proxetil Nanosuspension by using 23 Factorial Design. Res J Pharm Technol. 2025; 18(6).
34. Afreen U, Fahelelbom KM, Shah SNH, Ashames A, Almas U, Khan SA, Yameen M, Nisar N, Asad M, Murtaza G. Formulation and Evaluation of Niosomes-based Chlorpheniramine Gel for the Treatment of Mild to Moderate Skin Allergy. J Exp Nanosci. 2022; 17(1): 467–95.
35. Sangkana S, Eawsakul K, Ongtanasup T, Boonhok R, Mitsuwan W, Chimplee S, Paul A, Saravanabhavan S, Mahboob T, Nawaz M, Pereira M, Wilairatana P, Wiart C, Nissapatorn V. Preparation and Evaluation of a Niosomal Delivery System Containing G. mangostana Extract and Study of Its Anti-Acanthamoeba Activity. Nanoscale Adv. 2024; 6(5): 1467–79.
36. Joshi S, White R, Sahu R, Dennis VA, Singh SR. Comprehensive Screening of Drug Encapsulation and Co-Encapsulation Into Niosomes Produced Using a Microfluidic Device. Processes. 2020; 8(5).
37. Yaghoobian M, Haeri A, Bolourchian N, Shahhosseni S, Dadashzadeh S. The Impact of Surfactant Composition and Surface Charge of Niosomes on The Oral Absorption of Repaglinide as a BCS II Model Drug. Int J Nanomedicine. 2020; 15: 8767–81.
38. Skiba M, Skiba-Lahiani M, Marchais H, Duclos R, Arnaud P. Stability Assessment of Ketoconazole in Aqueous Formulations. Int J Pharm [Internet]. 2000; 198: 1–6. Available from: www.elsevier.com/locate/ijpharm
39. Obeid MA, Khadra I, Aljabali AAA, Amawi H, Ferro VA. Characterisation of Niosome Nanoparticles Prepared by Microfluidic Mixing for Drug Delivery. Int J Pharm X. 2022; 4.
40. Herawati D, Pudjiastuti P, Zaidan AH, Hendradi E. K-Carrageenan Folate Nanoencapsulation of Fucoidan from Sargassum plagiophyllum and Anticancer Activity Enhancement. Res J Pharm Technol. 2025; 18(6).
41. Moammeri A, Chegeni MM, Sahrayi H, Ghafelehbashi R, Memarzadeh F, Mansouri A, Akbarzadeh I, Abtahi M, Hejabi F, Ren Q. Current Advances in Niosomes Applications for Drug Delivery and Cancer Treatment. Materials Today Bio. 2023; 23.
42. Stoyanov Vassilev D, Petkova NT, Koleva M. Optimization Of Ultrasound Synthesis Of Sucrose Esters By Selection Of A Suitable Catalyst and Reaction Conditions. Available from: https://www.researchgate.net/publication/349342963
43. Szuts A, Szabó-Révész P. Sucrose esters as natural surfactants in drug delivery systems - A mini-review. International Journal of Pharmaceutics. 2012; 433: 1–9.
44. Indra I, Janah FM, Aryani R. Enhancing the Solubility of Ketoconazole via Pharmaceutical Cocrystal. In: Journal of Physics: Conference Series. Institute of Physics Publishing; 2019.
45. Witika BA, Bassey KE, Demana PH, Siwe-Noundou X, Poka MS. Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications. International Journal of Molecular Sciences. 2022; 23.
46. Katrolia A, Chauhan SB, Shukla VK. Formulation and evaluation of Metformin Hydrochloride-loaded Curcumin–Lycopene Niosomes. SN Appl Sci. 2019; 1(12).